<DOC>
	<DOC>NCT02509923</DOC>
	<brief_summary>The purpose of this study is to evaluate pharmacokinetics and pharmacodynamics of Z-215 (10 mg, 20 mg, 40 mg) , compared with Rabeprazole Sodium (10 mg, 20 mg ) in Healthy Male Subjects. And to evaluate food-effect in Healthy Male Subjects administrated Z-215 20 mg.</brief_summary>
	<brief_title>To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Rabeprazole</mesh_term>
	<criteria>Has negative results for H. pylori IgG antibody at screening. A body mass index 18.5≦BMI&lt;25.0 kg/m^2 at screening. Able to understand the consent of the study and comply with the study. Able to give informed consent in writing before participating in the study. Has a history of PPI allergy. Has a history of drug or food serious allergy. Presently has or has a history of diseases that may affect evaluation of the study results such as gastrointestinal, hepatic, renal, respiratory, endocrine, blood, cardiovascular, mental or congenial metabolic disease. Has a history of surgery (such as resection of the liver, kidney, or digestive tract) that may affect the pharmacokinetics of the study drug. History of previous and current acidrelated diseases. Received H. pylori eradication treatment within 6 months before screening. Has 450msec&lt;QTC by Fridericia test at screening ECG . Has hypoacidity or anacidity. Or be determined that low gastric acid or no stomach acid by the gastric pH monitoring at baseline period. History or suspicion of drug, opioid, alcohol abuse or positive screening results. Use of any prescription drugs within 4 weeks prior to baseline period. Use of any overthecounter drugs within 2 weeks prior to baseline period. Received blood transfusions within 12 weeks or donated ≥400mL of whole blood within 12 weeks or ≥200mL of whole blood within 4 weeks prior to baseline period. Donated platelet or plasma within 2 weeks prior to baseline period.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Male Subjects</keyword>
</DOC>